$0.610
+0 (+0%)
At Close: Jun 03, 2026
Oragenics, Inc. Announces Enrollment Of 60th Patient In Clinical Trial
12:00am, Friday, 15'th Mar 2019Biotech Outlook 2019: Will the Pressure Continue? | INN
07:30am, Thursday, 20'th Dec 2018
With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in the space.
Sign In
Buy OGEN